Marc Pudlo

964 total citations
30 papers, 727 citations indexed

About

Marc Pudlo is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Marc Pudlo has authored 30 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Marc Pudlo's work include Computational Drug Discovery Methods (6 papers), Synthesis and biological activity (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Marc Pudlo is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Synthesis and biological activity (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Marc Pudlo collaborates with scholars based in France, Ukraine and Spain. Marc Pudlo's co-authors include C. Girard, Céline Demougeot, Tijani Gharbi, Bernard Refouvelet, Lhassane Ismaïli, Vincent Luzet, János Sápi, José Marco‐Contelles, Zsuzsanna Riedl and György Hajós and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Chemical Communications.

In The Last Decade

Marc Pudlo

27 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Pudlo France 14 303 238 153 98 95 30 727
Jiang‐Ke Qin China 16 258 0.9× 251 1.1× 175 1.1× 88 0.9× 56 0.6× 48 796
Livia Basile Italy 16 210 0.7× 316 1.3× 145 0.9× 59 0.6× 90 0.9× 47 697
Eduarda Mendes Portugal 17 336 1.1× 328 1.4× 262 1.7× 55 0.6× 164 1.7× 38 900
Ban‐Feng Ruan China 22 676 2.2× 395 1.7× 127 0.8× 54 0.6× 85 0.9× 79 1.3k
M. Alaraby Salem Egypt 14 182 0.6× 122 0.5× 92 0.6× 79 0.8× 80 0.8× 21 696
Aurélie Malzert‐Fréon France 16 156 0.5× 243 1.0× 125 0.8× 73 0.7× 81 0.9× 40 677
Aarfa Queen India 16 237 0.8× 523 2.2× 136 0.9× 37 0.4× 141 1.5× 21 919
Rahul P. Gangwal India 15 162 0.5× 355 1.5× 56 0.4× 64 0.7× 117 1.2× 29 861
Zsófia Kutil Czechia 20 162 0.5× 645 2.7× 133 0.9× 26 0.3× 88 0.9× 39 992

Countries citing papers authored by Marc Pudlo

Since Specialization
Citations

This map shows the geographic impact of Marc Pudlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Pudlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Pudlo more than expected).

Fields of papers citing papers by Marc Pudlo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Pudlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Pudlo. The network helps show where Marc Pudlo may publish in the future.

Co-authorship network of co-authors of Marc Pudlo

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Pudlo. A scholar is included among the top collaborators of Marc Pudlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Pudlo. Marc Pudlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Garnier, François, et al.. (2025). Design, programming, and evaluation of a serious game web application to memorise drug classification and properties. Currents in Pharmacy Teaching and Learning. 17(6). 102335–102335.
3.
Luzet, Vincent, Alexandre Bonet, Dominique Harakat, et al.. (2024). Synthesis and evaluation of lipoic acid – donepezil hybrids for Alzheimer’s disease using a straightforward strategy. Bioorganic & Medicinal Chemistry Letters. 112. 129938–129938. 2 indexed citations
4.
Pudlo, Marc, et al.. (2023). Arginase inhibitory activities of chemical constituents from Macaranga hurifolia Beille leaves. Natural Product Research. 38(23). 4286–4291. 4 indexed citations
5.
Decombat, Caroline, et al.. (2021). A skills framework integrating professionally relevant medicinal chemistry proficiencies to strengthen the contemporary practice of pharmacy. Annales Pharmaceutiques Françaises. 80(2). 176–186. 1 indexed citations
6.
Pudlo, Marc, et al.. (2021). An Update on Arginase Inhibitors and Inhibitory Assays. Mini-Reviews in Medicinal Chemistry. 22(15). 1963–1976. 2 indexed citations
7.
Pudlo, Marc, et al.. (2020). Human-based evidence for the therapeutic potential of arginase inhibitors in cardiovascular diseases. Drug Discovery Today. 26(1). 138–147. 7 indexed citations
8.
Bourjot, Mélanie, et al.. (2017). In Vitro Mammalian Arginase Inhibitory and Antioxidant Effects of Amide Derivatives Isolated from the Hempseed Cakes (Cannabis sativa). Planta Medica International Open. 3(3). e64–e67. 19 indexed citations
9.
Totoson, Perle, Alain Décendit, Alain Badoc, et al.. (2017). Cyperaceae Species Are Potential Sources of Natural Mammalian Arginase Inhibitors with Positive Effects on Vascular Function. Journal of Natural Products. 80(9). 2432–2438. 23 indexed citations
10.
Borg, Christophe, Hatem Boulahdour, Tijani Gharbi, et al.. (2016). Nanovectorization of DNA Through Cells Using Protamine Complexation. The Journal of Membrane Biology. 249(4). 493–501. 4 indexed citations
11.
Pudlo, Marc, et al.. (2016). A Modeling Approach towards Identifying Potential Bivalent Sensitizersof Neuromuscular Blocking Agents. 5(2).
12.
Hervouet, Éric, C. Girard, Tijani Gharbi, et al.. (2016). Carbon nanotubes as gene carriers: Focus on internalization pathways related to functionalization and properties. Acta Biomaterialia. 49. 36–44. 64 indexed citations
13.
Picaud, Fabien, Claire‐Hélène Brachais, David Monchaud, et al.. (2015). Carbon nanotube – Protamine hybrid: Evaluation of DNA cell penetration. Carbon. 96. 742–752. 13 indexed citations
14.
Picaud, Fabien, Marc Pudlo, Lucien Saviot, et al.. (2015). Nanovectorization of TRAIL with Single Wall Carbon Nanotubes Enhances Tumor Cell Killing. Nano Letters. 15(2). 891–895. 73 indexed citations
15.
Pallandre, Jean‐René, Christophe Borg, Didier Rognan, et al.. (2015). Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors. European Journal of Medicinal Chemistry. 103. 163–174. 31 indexed citations
16.
Benchekroun, Mohamed, Lhassane Ismaïli, Marc Pudlo, et al.. (2015). Donepezil–Ferulic Acid Hybrids as Anti-Alzheimer Drugs. Future Medicinal Chemistry. 7(1). 15–21. 58 indexed citations
17.
Pudlo, Marc, et al.. (2014). Quinolone–benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease. Bioorganic & Medicinal Chemistry. 22(8). 2496–2507. 68 indexed citations
18.
Pudlo, Marc, et al.. (2012). First domino radical cyclisation/Smiles rearrangement combination. Chemical Communications. 48(18). 2442–2442. 43 indexed citations
19.
Ismaïli, Lhassane, Marc Pudlo, Cristóbal de los Rı́os, et al.. (2010). Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists. European Journal of Medicinal Chemistry. 46(1). 1–10. 47 indexed citations
20.
Pudlo, Marc, Stéphane Gérard, Catherine Mirand, & János Sápi. (2007). A tandem radical cyclization approach to 3-(2-oxopyrrolidin-3-yl)indolin-2-ones, potential intermediates toward complex indole-heterocycles. Tetrahedron Letters. 49(6). 1066–1070. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026